Skip to content

Amneal Pharmaceuticals

US · AMRX #1854 by market cap Listed 1970
21.12 -0.27 -1.26%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

Quant vs Street three independent views, side by side

StockVane factor grade
C
Momentum strategy signal
Hold
Analyst consensus
Buy

Mostly aligned, one view stands apart.

Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.

Analyst consensus 5 analysts

Buy
Avg price target 24.40 +15.5%
Price target rangecurrent 21.12
Low20.00
Avg24.40
High28.00
Buy 100% Hold 0% Sell 0%
Recent ratings (25)
DateFirmAnalystRatingTarget
2026-11-09 UBS -- Buy 28.00
2026-11-06 UBS -- Buy 28.00
2026-11-05 Leerink Partners -- Buy 25.00
2026-11-04 J.P. Morgan -- Buy 25.00
2026-10-29 Goldman Sachs -- Buy 24.00
2026-10-22 J.P. Morgan -- Buy 24.00
2026-09-23 Oppenheimer -- Buy 27.00
2026-09-21 Barclays -- Buy 20.00
2026-09-21 J.P. Morgan -- Buy --
2026-09-17 Leerink Partners -- Buy 23.00
2026-09-16 Barclays -- Buy 20.00
2026-09-09 Leerink Partners -- Buy 23.00
2026-08-26 J.P. Morgan -- Buy 22.00
2026-08-10 Goldman Sachs -- Buy 21.00
2026-08-03 UBS -- Buy 25.00
2026-07-15 UBS -- Buy 23.00
2026-06-11 UBS -- Buy --
2026-06-11 Barclays -- Buy 16.00
2026-06-04 Piper Sandler -- Buy 17.00
2026-05-26 Piper Sandler -- Buy 17.00
2026-05-20 Barclays -- Buy 16.00
2026-04-23 Truist Financial -- Buy --
2026-04-17 UBS -- Buy 19.00
2026-04-16 UBS -- Buy 19.00
2026-03-18 Barclays -- Buy 15.00

Price target trend monthly average, last 3 years

Earnings history price reaction on the day

PeriodReport dateSessionOptions expectedActual move
2026/Q3 2026-11-03 -- ±13.81% -1.13% (in line)
2026/Q2 2026-07-30 -- ±15.06% -3.14% (in line)
2026/Q1 2026-05-01 -- ±15.15% -0.31% (in line)
2025/Q4 2026-02-27 -- ±14.84% -4.69% (in line)
2025/Q3 2025-10-30 -- ±12.46% -4.12% (in line)
2025/Q2 2025-08-05 -- ±14.20% +2.14% (in line)
2025/Q1 2025-05-02 -- ±14.34% +2.97% (in line)
2024/Q4 2025-02-28 -- ±24.95% +3.46% (in line)
2024/Q3 2024-11-08 -- ±12.78% +1.39% (in line)
2024/Q2 2024-08-09 -- ±15.59% -1.54% (in line)
2024/Q1 2024-05-03 -- ±24.96% +8.86% (in line)
2023/Q3 2023-11-07 -- ±31.35% +2.38% (in line)

"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.

Quote time 2026-11-20 20:02:15 · For reference only, not investment advice and not tailored to your situation.

Amneal Pharmaceuticals discussion 0 comments

Add a comment